2022 Companion Diagnostic Special Research Initiative Officially Launched, Seeking Supporting Organizations

From Price Competition to Value-Based Competition: Accelerated Commercialization of Companion DiagnosticsCompanion diagnostics represent a specialized IVD technology, and in vitro diagnostics (IVD) has long been one of VCBeat’s key areas of focus. We have continuously tracked and studied the industry, having published nearly 20 sector-specific reports to date. In recent years, we have conducted in-depth thematic research on niche segments such as genetic testing, early cancer screening, and clinical mass spectrometry.

Companion diagnostics is one of the fastest-growing segments in the IVD market. As a cornerstone of precision medicine, it has demonstrated strong performance in clinical applications for treatment selection and prognostic testing. Being one of the most widespread and mature applications within precision medicine, it boasts broad application scenarios. With an improving policy environment and the continuous emergence of new technologies, its market potential is steadily increasing, along with its market share.

At the current stage of development, companion diagnostics have seen increased experimentation with new technologies, along with significant transformations in commercial pathways and service models. These changes warrant in-depth analysis; however, among the limited number of accessible research reports, discussions and analyses of novel business models for companion diagnostics remain scarce.

Based on the above background,VCBeat is set to launch a “Special Research Series on Companion Diagnostics” and is simultaneously seeking supporting organizations for its research projects. We sincerely invite enterprises with innovative achievements in this field to become our partners, using real-world case studies as a basis to jointly explore new developments and emerging trends.。

The following is a partialIVD Subsector Industry Research ReportExplore the industry's progress with VCBeat, if interested.Scan the QR code in the image to register your interest; additionally, internalAppendixFive latest research reports in niche fields such as "genetic testing" and "early cancer screening," canDownloadFor reference as a “Research Project Support Unit.”

This study centers on key themes such as “global expansion,” “penetration into grassroots healthcare,” “extended R&D collaborations with pharmaceutical companies,” and “single-cell sequencing,” to explore emerging technologies, channels, and business models. We will focus on dissecting new commercial models by surveying more than ten representative companies and investment institutions pursuing diverse technological pathways in the companion diagnostics field, thereby examining their explorations of commercialization strategies. Additionally, through interviews with 20 industry professionals, we aim to gather their perspectives and insights on the commercialization of companion diagnostics, delivering unique and valuable content for industry participants.

The research framework of this report is as follows:

• Industry Overview and Analysis: Medical Value, Market Size, Growth Drivers, Financing Trends, etc.;

• Analysis of New Technological Pathways: Characteristics and Applications of Emerging Technologies;

• Commercialization Innovation Exploration: New Models and New Channels;

• Future Development Trends: Strategic Implications for Enterprises Amid Technological and Regulatory Trends;

• Corporate Case Studies and Analysis: Innovations in Service Systems, Technological Advantages, and Business Models;

  
  

Cooperation Model:Please scan the QR code to complete the registration materials; supporting organizations may showcase their technological achievements and innovative case studies in appropriate sections of the research outcomes.

Fill inTime:September 16, 2022–September 30, 2022;

Report Topic:"2022 Companion Diagnostics Industry Research Report"

EnterpriseRequirements:

Representative Innovations in the Field of Companion Diagnostics: (The following innovation directions are for reference)

Technological R&D innovations, such as single-cell technology, mass spectrometry, digital PCR, NGS, AI, etc.;

Channel exploration and innovation, such as overseas expansion and penetration into grassroots markets;

Exploration of innovative models, such as extending collaborations with pharmaceutical companies and establishing joint initiatives within hospitals;

Innovation in business expansion, such as personalized medicine;

Other Representative Innovations.

Kind Reminder:For collaborations in other medical fields, please simply add a note when submitting the form.

To access and download the IVD industry research report, please scan the long image or QR code provided above.

(Note: The actual title and final framework of the report may be subject to adjustment based on research findings.)

AboutVCBeat

VCBeat Research Institute has consistently focused on innovation within the healthcare industry, which is undergoing transformation driven by a dual-engine strategy. Committed to empowering corporate executives, investment decision-makers, and policymakers with intellectual support through its data technology capabilities and in-depth industry research expertise, VCBeat aims to optimize decision-making outcomes, accelerate industrial development, and serve as an industry accelerator. With seven years of accumulated industry resources in the healthcare sector, it boasts the world’s largest medical

Innovation Enterprise Database: Approximately 70,000 innovative enterprises are included in the database, with deep outreach to over 20,000 enterprises and institutions.